[Disclosure] Samsung Biologics (207940) – Forecast of Operating Performance (Fair Disclosure) / 2026-01-21 Disclosures
[Disclosure] Samsung Biologics (207940) – Change in Revenue or Income Structure Exceeding 30% (15% for Large-Scale Corporations) / 2026-01-21 Disclosures
[Disclosure] Samsung Biologics (207940) – Provisional Performance (Fair Disclosure) / 2026-01-21 Disclosures
[Disclosure] Hanwha Aerospace (012450) – Pre-announcement of Earnings Release / 2026-01-20 Disclosures
[Disclosure] Hanwha Aerospace (012450) – Organization of Investor Relations Event / 2026-01-20 Disclosures
[Disclosure] Hanwha Aerospace (012450) – Organization of Investor Relations Event / 2026-01-20 Disclosures
![[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2026-01-21](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환한화오션.jpg)
![[Disclosure] Celltrion (068270) – Decision on Disposal of Treasury Shares / 2026-01-21](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환셀트리온.jpg)
![[Disclosure] Samsung Biologics (207940) – Forecast of Operating Performance (Fair Disclosure) / 2026-01-21](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환-삼성바이오로직스.jpg)
![[Disclosure] Hanwha Aerospace (012450) – Pre-announcement of Earnings Release / 2026-01-20](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환-한화에어로스페이스.jpg)